|
KMID : 1146320170050010022
|
|
Journal of Health Technology Assessment
2017 Volume.5 No. 1 p.22 ~ p.30
|
|
|
Strategy for Globalization of Korean Medicine Anti-Cancer Drugs
|
|
Park Kyoung-Hoon
Lee Joong-yub
Choi Hyun-Jin
Kim Seon-Ji
Park Byung-Joo
|
|
|
Abstract
|
|
|
|
Cancer is the leading cause of death worldwide and the most important cause of death in Korea. Many researches have been conducted for developing effective and safe anti-cancer drugs worldwide. Korean government recently declared to make traditional herbal medicine globally recognized and began to invest not a small budget for developing new promising herbal anti-cancer drugs. The purpose of this study is to investigate the scientific evidence of current Korean herbal medicines to be able to enter the world market through the studies of NEXIA. NEXIA (Rhus verniciflua Stokes), anticancer drug from traditional herbal medicine in Korea, has been used by Korean medicine physician legally without Ministry of Drug and Food Safety’s formal approval through a new drug approval system. We have found the studies on the NEXIA have not enough scientific evidence on safety and effectiveness due to lack of internal validity of the studies. In order to make our traditional herbal anti-cancer drugs successfully enter the world market, we have to establish effective system for evaluating them through the world-widely recognized system such as clinical trial system of cancer drugs run by the U.S Food and Drug Administration. It should be prerequisite to establish sound evaluation system for safety and effectiveness of Korean herbal anti-cancer drugs for developing globally acceptable Korean herbal anti-cancer drugs.
|
|
|
KEYWORD
|
|
|
Korean traditional anti-cancer drug, Cancer clinical trials, Globalization, NEXIA
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|